A facile one-pot synthesis of thiazoles and thiazolyl-pyrazole derivatives via multicomponent approach by Santhosh Penta & Rajeswar Rao Vedula
ORIGINAL ARTICLE      
 
The article was published by Academy of Chemistry of Globe Publications 
www.acgpubs.org/OC/index.htm © Published 07/20/2012 EISSN:1307-6175 
 
 
 
 
 
 
Org. Commun.5:3 (2012) 143-149 
 
RETRACTED: A facile one-pot synthesis of thiazoles and 
thiazolyl-pyrazole derivatives via multicomponent approach 
 
Santhosh Penta and Rajeswar Rao Vedula
* 
Department of Chemistry, National Institute of Technology, Warangal-506 004, A.P, India. 
 (Received February 26, 2012; Revised May 3, 2012; Accepted July 1, 2012) 
 
Abstract: Thiazoles and thiazolyl-pyrazole derivatives have been efficiently synthesized under neat reaction 
conditions  in  excellent  yields.  Condensation  of  3-(2-bromoacetyl)-4-hydroxy-6-methyl-2H-pyran-2-one  (1), 
thiosemicarbazide (2) and various carbonyl compounds (3 & 5) gave corresponding thiazole (4) and thiazolyl-
pyrazole derivatives (6) in excellent yields by using Hantzsch-Thiazole synthesis.  The main advantage of this 
method is the short reaction time, high yields, simple workup and environmental benign process. The structures 
of newly synthesized compounds have been established by elemental analysis and spectral data. 
 
Keywords:  Thiazole;  thiazolyl-pyrazole;  3-(2-bromoacetyl)-4-hydroxy-6-methyl-2H-pyran-2-one;  multi-
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derivatives via multicomponent approach ″[1]due to duplicated publication in another journal  with a similar 
content [2]. 
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1. Introduction 
 
Heterocycles are widely used in the development of modern pharmaceuticals, this being one of 
the reasons why continuous efforts are placed towards the design of amenable synthetic approaches for 
the  synthesis  of  new  heterocyclic  systems.  3-Acetyl-4-hydroxy-6-methyl-2H-pyran-2-one 
(Dehydroacetic acid) is a versatile starting material and its derivatives find wider application in the 
synthesis of heterocyclic compounds.
1-8  Dehydroacetic acid is a pyran derivative and exhibit high 
biological  activity.
9  For  example,  sodium  dehydroacetate  in  rats  induces  severe  hemorrhaging  in 
multiple organs and prolongation of blood coagulation factors.
10 For instance, 4-hydroxy-2-pyrones 
are considered as one important class of anti-HIV agents and exhibit a wide range of antifungal, 
phytotoxic,  antimicrobial,  cytotoxic  and  neurotoxic  activities.
11,12  Other  2-pyrone  derivatives  have 
shown  a  huge  potential  in  the  treatment  of  Alzheimer’s  diseases.
13  The  nitrogen  and  sulfur 
heterocyclic systems are very interesting because of their physicochemical properties with relevance to 
the design of new drugs. In those compounds containing thiazole ring plays a prominent role in nature 
as they are found in numerous biologically active compounds. Thiazole ring systems are known to 
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possess various pharmacological properties such as anti-tubercular, antifungal, analgesic and anti-
cancer  activity.
14-17  The  thiazole  derivatives  niridazole  and  levamisole  are  used  as  antihelmintic 
drugs
18-19 and ritonavir is a antiretroviral drug from the protease inhibitor class used to treat HIV 
infection and AIDS.
20 Pyrazoles have emerged as a group of compounds possessing a broad spectrum 
of useful medicinal properties such as herbicides, fungicides and analgesics activities.
21-22 Schiff bases 
form  a  significant  class  of  compounds  in  medicinal  and  pharmaceutical  chemistry  with  several 
biological  applications  that  include  antibacterial,  antifungal  and  antitumor  activity.
23-29  Multi-
component reactions (MCRs) involve domino processes  “in which more than three different reactants 
directly get converted into their products by one-pot reaction’’.
30 MCRs play an important role in 
modern organic chemistry, because they generally exhibit higher atom economy, selectivity, molecular 
complexity  and  diversity  as  well  as  produce  fewer  by-products  compared  to  classical  multistep 
synthesis.
31 
 
It is known that 2-aminothiazoles can be synthesized from α-bromoketone and a thiourea via a 
Hantzsch thiazole synthesis in high yields.
32-33 A literature survey revealed that, there are numerous 
routes reported for the synthesis of substituted thiazoles according to Hantzsch-thiazole synthesis.
34-36 
These methods give excellent yields for thiazoles. However, for some substituted thiazoles low yields 
have been reported as a result of dehalogenation of the α-haloketone during the reaction. 
Based on the above observations and as a part of our research program in the synthesis of 
novel heterocyclic systems,
37-41 a facile route has been described for the synthesis of thiazoles and 
thiazolyl-pyrazole derivatives with pyran moiety via Hantzsch-thiazole multicomponent reaction.  
 
2. Results and Discussion 
Reaction of equimolar mixture of 3-(2-bromoacetyl)-4-hydroxy-6-methyl-2H-pyran-2-one (1), 
thiosemicarbazide (2) and various carbonyl compounds (3) and acetyl acetone (5) on stirring at room 
temperature  for  period  of  10  min  resulted  in  the  formation  of  4-hydroxy-3-[2-(N′-substituted-
hydrazino)-thiazol-4-yl]-6-methyl-pyran-2-one (4a-j) and 4-hydroxy-6-methyl-3-(2-(3,5-dimethyl-1H-
pyrazol-1-yl)thiazol-4-yl)-2H-pyran-2-one derivatives (6) in good yields.       
In this reaction, a plausible mechanism for the formation of 4 can be proposed. The bromine 
atom  of  3-(2-bromoacetyl)-4-hydroxy-6-methyl-2H-pyran-2-one  is  replaced  by  sulfur  atom  of 
thiosemicarbazide to yield an open chain α-thio ketone, which under trans-protonation proceeds to 
give 4-hydroxy thiazoline derivative. This subsequently undergoes dehydration to give 2-hydrazino 
thiazole derivative (in situ). This subsequently undergoes condensation reaction with various carbonyl 
compounds to give final product 4. This is in accordance with modified Hantzsch-Thiazole synthesis. 
In the formation of thiazolyl-pyrazole 6 it is believed that first thioamide part of thiosemicarbazide 
undergoes  condensation  with  loss  of  water  and  HBr  molecules  to  gave  cycloproduct  of  3-(2-
hydrazino-thiazol-4-yl)-4-hydroxy-6-methyl-pyran-2-one. This further undergoes to condensation with 
acetyl acetone to give final product. In this reaction, two heterocyclic ring systems, thiazole and a 
pyrazole, were developed simultaneously. 
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Scheme-1:  One-pot  synthesis  of  4-hydroxy-3-[2-(N′-substitutedaryl-hydrazino)-thiazol-4-yl]-6-
methyl-pyran-2-one 4a-j and 4-hydroxy-6-methyl-3-(2-(3,5-di methyl-1H-pyrazol-1-yl)thiazol-4-yl)-
2H-pyran-2-one 6. 
 
The IR spectrum of compound 4b showed prominent peaks at 1731cm
-1 for lactone, 3367 cm
-1 
to the hydroxyl of pyran ring. 
1H NMR of compound 4b showed characteristic singlets for –CH3 of 
pyran at δ 2.24, the C-5 proton of pyran ring singlet at δ 6.23, thiazole proton appeared as singlet at δ 
7.81. The above spectral data confirmed the structure of compound 4b. The 
13C NMR spectrum of 4b 
also shows the peaks at δ 14.2 and 19.3 for two methyl carbons, 101.1 and 168.5 for C-5 of pyran 
carbon  and  C=O  of  pyran  respectively.  In  the  same  way 
1H  NMR  of  compound  6  showed 
characteristic singlets for –CH3 of pyran at δ 2.22, the pyrazole methyl groups appeared as singlet at δ 
2.27 and δ 2.62 respectively. The C-5 proton of pyran ring and pyrazole proton appeared as singlet at δ 
6.30, while the thiazole proton appeared as singlet at δ 7.89. The remaining protons were observed in 
the expected region. The above spectral data confirmed the structure of the compound 6. All the above 
spectral data clearly indicates the formation of title products. 
 
3. Conclusion 
 
In conclusion, a facile one-pot reaction has been described for the synthesis of aryl and heteryl 
2,4-disubstituted  thiazoles  and  thiazolyl-pyrazole  derivatives  via  multi-component  approach  using 
readily available starting materials. This method does not involve the use of volatile organic solvents 
thus it is an environmentally friendly process. These highly functionalized derivatives may be of 
interest for pharmaceutical purposes, yet to be explored. 
 
 
 
 
4. Experimental 
 
All the reagents and solvents were purchased from commercial sources and were used without 
further purification unless otherwise stated. 3-(2-Bromoacetyl)-4-hydroxy-6-methyl-2H-pyran-2-one
38 
was  prepared  by  literature  procedure.  Melting  points  were  determined  in  open  capillaries  with  a 
“Cintex” melting point apparatus Mumbai, India and were uncorrected. CHNS analysis was done by 
Carlo Erba EA 1108 automatic elemental analyzer. The purity of the compounds was checked by TLC 
plates (E. Merck Mumbai, India). IR spectra (KBr) were recorded on a Thermo Nicolet Nexus 670 
spectrometer. 
1H-NMR spectra were recorded on a Bruker WM-400 spectrometer in δ ppm using TMS 
as standard. Mass spectra (EI-MS) were determined on Perkin Elmer (SCIEX API- 2000, ESI) at 
12.5ev. 
 
General procedure for the preparation of compounds 4a-j: 
 
An  equimolar  mixture  of  3-(2-bromoacetyl)-4-hydroxy-6-methyl-2H-pyran-2-one 
(1mmol, 1eq) and thiosemicarbazide (1mmol, 1eq) with various carbonyl compounds (1 mL) A facile one-pot synthesis of thiazoles and thiazolyl-pyrazole  
 
on stirring at room temperature for about 10 min gave the solid. It was filtered and washed 
with cold methanol. The crude product recrystalized from ethanol. 
  
4-Hydroxy-3-[2-(N′-isopropylidene-hydrazino)-thiazol-4-yl]-6-methyl-pyran-2-one (4a): 
Yield 92%; mp 182-184
oC, Color: light yellow; IR, υ, cm
–1: 1717(lactone C=O), 3251 (NH), 3370 (-
OH). 
1H NMR (DMSO-d6), δ, ppm: 1.96 (s, 6H, 2xCH3), 2.23 (s, 3H, CH3), 6.20 (s, 1H, pyran proton), 
7.31 (s, 1H, thiazole), 11.11 (s, 1H, NH), 14.57 (s, 1H, OH). 
13C NMR (DMSO-d6, δ ppm): 17.9 
(CH3), 19.3(CH3), 24.7(CH3), 93.8, 101.1, 103.3, 140.8, 152.9, 161.7, 162.0, 168.0, 168.6(C=O). ESI-
MS 278 [M-H]
+. Anal. calcd. For C12H13N3O3S: C, 51.60; H, 4.69; N, 15.04, S, 11.48;  Found:  C, 
51.5; H, 4.63; N,15.12; S, 11.52. 
  
4-Hydroxy-6-methyl-3-{2-[N′-(1-phenyl-ethylidene)-hydrazino]-thiazol-4-yl}-pyran-2-one (4b):  
Yield  80%,  mp  197-199
oC,  Color:  light  yellow;  IR,  υ,  cm
–1:  1731  (lactone  C=O),  3247(NH), 
3367(OH). 
1H NMR (DMSO-d6), δ, ppm: δ 2.24 (s, 3H, CH3), 2.35 (s, 3H, CH3), 6.23 (s, 1H, pyran 
proton), 7.39-7.46 (m, 5H, ArH), 7.81 (s, 1H, thiazole), 11.57 (s, 1H, -NH), 14.50 (s, 1H, -OH). 
13C 
NMR (DMSO-d6, δ ppm): 14.2(CH3), 19.3(CH3), 94.1, 101.1, 104.0, 125.8, 128.4, 129.1, 137.3, 142.2, 
148.5,  161.5,  161.9,  168.2,  168.5(C=O).  ESI-MS  340  [M-H]
+.  Anal.  calcd.  For  C17H15N3O3S:  C, 
59.81; H, 4.43; N, 12.31, S, 9.39; Found: C, 59.85; H, 4.40; N, 13.26; S, 9.34. 
 
4-Hydroxy-6-methyl-3-{2-[N′-(1-p-tolyl-ethylidene)-hydrazino]-thiazol-4-yl}-pyran-2-one (4c):  
Yield 80%, mp 237-239
oC, Color: light yellow; IR , υ, cm
–1: 1727 (lactone C=O), 3248 (NH), 3377 
(OH). 
1H NMR (DMSO-d6), δ, ppm: 2.24 (s, 3H, CH3), 2.32 (s, 3H, CH3), 2.33 (s, 3H, CH3), 6.22 (s, 
1H, pyran proton), 7.25 (d, 2H, J=8.0Hz, ArH, part of AA'BB'), 7.41 (s, 1H, thiazole), 7.70 (d, 2H, 
J=8.4Hz, ArH, part of AA'BB'), 11.50 (s, 1H, -NH), 14.90 (s, 1H, -OH).
 13C NMR (DMSO-d6, δ ppm): 
14.2(CH3), 19.3(CH3), 20.8(CH3), 93.9, 101.1, 104.0, 125.8, 129.0, 134.5, 138.8, 141.5, 148.9, 161.6, 
161.9, 168.0, 168.5(C=O). ESI-MS 356 [M+H]
+. Anal. calcd. For C18H17N3O3S: C, 60.83; H, 4.82; N, 
11.82, S, 9.02;  Found:  C, 60.78; H, 4.78; N, 11.76; S, 9.12. 
 
4-Hydroxy-3-(2-{N′-[1-4-methoxy-phenyl)-ethylidene]-hydrazino}-thiazol-4-yl)-6-methyl-pyran-
2-one (4d): Yield 82%, mp 232-234
oC, Color: light yellow; IR , υ, cm
–1: 1728 (lactone C=O), 3263 
(NH), 3370 (OH). 
1H NMR (DMSO-d6), δ, ppm: 2.24 (s, 3H, of CH3), 2.31 (s, 3H, CH3), 3.80 (s, 3H, 
OCH3), 6.22 (s, 1H, pyran proton), 6.99 (d, 2H, J=8.8Hz, ArH), 7.40 (s, 1H, thiazole), 7.75 (d, 2H, 
J=8.8Hz, ArH), 11.47 (s, 1H, -NH), 14.87 (s, 1H, -OH). 
13C NMR (DMSO-d6, δ ppm): 14.1(CH3), 
19.3(CH3),  55.2(CH3), 94.2,  101.1,  103.6,  113.8,  127.3,  129.8,  142.5,  148.3, 160.1,  161.5,  161.8, 
168.3, 168.5(C=O). ESI-MS 372 [M+H]
+. Anal. calcd. For C18H17N3O4S: C, 58.21; H, 4.61; N, 11.31, 
S,8.63; Found: C, 58.26; H, 4.56; N, 11.34; S, 8.68.  
 
3-[2-(N′-sec-Butylidene-hydrazino]-thiazol-4-yl]-4-hydroxy-6-methyl-pyran-2-one  (4e):  Yield 
80%, mp 216-218
oC, Color: light yellow; IR, υ, cm
–1: 1721 (lactone C=O), 3261 (NH), 3392 (OH). 
1H 
NMR (DMSO-d6), δ, ppm: 1.06 (t, 3H, J=7.6Hz, CH3), 1.94 (s, 3H, CH3), 2.23 (s, 3H, CH3), 2.29 (q, 
2H, J=7.6Hz, CH2), 6.20 (s, 1H, pyran proton), 7.33 (s, 1H, thiazole), 11.22 (s, 1H, NH), 14.82 (s, 1H, 
OH). 
13C NMR (DMSO-d6, δ ppm): 10.3(CH3), 16.7(CH3), 19.3(CH3), 31.0(CH2), 93.5, 101.0, 103.5, 
139.7, 156.9, 161.8, 162.1, 168.0, 168.6(C=O). EI-MS 293 [M]
+. Anal. calcd. For C13H15N3O3S: C, 
53.23; H, 5.15; N, 14.32, S, 10.93; Found: C, 53.18; H, 5.10; N, 14.27; S, 10.88.  
 
3-[2-(N′-Cyclohexylidene-hydrazino]-thiazol-4-yl]-4-hydroxy-6-methyl-pyran-2-one  (4f):  Yield 
81%, mp 256-258
oC, Color: light yellow; IR, υ, cm
–1: 1737 (lactone C=O), 3252 (NH), 3420 (OH). 
1H 
NMR (DMSO-d6), δ, ppm: 1.60-1.63 (m, 6H, 3xCH2 of cyclohexyl), 2.23 (s, 3H, CH3), 2.27-2.29 (m, 
2H, CH2), 2.43-2.46 (m, 2H, CH2 of cyclohexyl), 6.21 (s, 1H, pyran proton), 7.33 (s, 1H, thiazole), 
11.50  (s,  1H,  -NH),  14.77  (s,  1H,  -OH). 
13C  NMR  (DMSO-d6,  δ  ppm):  19.4(CH3),  24.8(CH2), 
25.5(CH2), 26.7(CH2), 27.7(CH2), 34.6(CH2), 93.0, 100.9, 104.0, 137.9, 160.1, 162.0, 162.4, 167.7, 
168.6(C=O). ESI-MS 320 [M+H]
+. Anal. calcd. For C15H17N3O3S: C, 56.41; H, 5.37; N, 13.16, S, 
10.04; Found: C, 56.37; H, 5.32; N, 13.12; S, 10.12. 
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3-[2-(N′-Benzylidene-hydrazino]-thiazol-4-yl]-4-hydroxy-6-methyl-pyran-2-one (4g): Yield 77%, 
mp 227-229
oC, Color: light yellow; IR, υ, cm
–1: 1728 (lactone C=O), 3217 (NH), 3431 (OH). 
1H NMR 
(DMSO-d6), δ, ppm: 2.24 (s, 3H, CH3), 6.22 (s, 1H, pyran proton), 7.41-7.47 (m, 6H, 5ArH, 1H2 
thiazole), 8.08 (s, 1H, CH=N), 12.47 (s, 1H, -NH), 14.88 (s, 1H, -OH). 
13C NMR (DMSO-d6, δ ppm): 
16.3(CH3),  99.9,  128.4,  128.5,  129.0,  129.1,  152.3,  156.5,  161.1,  162.1,  162.8,  163.9,  166.7, 
168.2(C=O). ESI-MS 328 [M+H]
+. Anal. calcd. For C16H13N3O3S: C, 58.70; H, 4.00; N, 12.84, S, 
9.80. Found:  C, 58.65; H, 3.96; N, 12.80; S, 9.75.  
 
4-Hydroxy-3-{2-[N′-(2-hydroxy-benzylidene)-hydrazino]-thiazol-4-yl}-6-methyl-pyran-2-one 
(4h): Yield 87%, mp 243-245
oC, Color: light yellow; IR, υ, cm
–1: 1707 (lactone C=O), 3207 (NH), 
3370 (OH). 
1H NMR (DMSO-d6), δ, ppm: 2.24 (s, 3H, CH3), 6.23 (s, 1H, pyran proton), 6.85-6.92 (m, 
4H, ArH), 7.33 (s, 1H, thiazole), 8.06 (s, 1H, CH=N), 11.32 (s, 1H, -NH), 14.82 (s, 1H, -OH). 
13C 
NMR (DMSO-d6, δ ppm): 19.8(CH3), 94.9, 101.4, 104.0, 116.5, 116.6, 119.7, 120.2, 126.7, 131.5, 
143.4, 156.6, 161.8, 162.4, 167.3, 168.8(C=O). ESI-MS 342 [M-H]
+.  Anal. calcd. For C16H13N3O4S: 
C, 55.97; H, 3.82; N, 12.24; S, 9.34; Found: C, 55.93; H, 3.78; N, 12.20; S, 9.30.  
 
4-Hydroxy-6-methyl-3-{2-[N′-(4-methyl-benzylidene)-hydrazino]-thiazol-4-yl}-pyran-2-one (4i):  
Yield 80%, mp 237-239
oC, Color: light yellow; IR, υ, cm
–1: 1717 (lactone C=O), 3242 (NH), 3366 
(OH). 
1H NMR (DMSO-d6), δ, ppm: 2.24 (s, 3H, CH3), 2.34 (s, 3H, CH3), 6.22 (s, 1H, pyran proton), 
7.26 (d, 2H, J=8.0Hz, ArH, part of AA'BB'), 7.41 (s, 1H, thiazole),  7.59 (d, 2H, J=8.0Hz, ArH, part of 
AA'BB'), 8.05 (s, 1H, CH=N), 12.42 (s, 1H, NH), 14.82 (s, 1H, OH). 
13C NMR (DMSO-d6, δ ppm): 
19.4(CH3),  21.0(CH3), 94.0,  104.0,  126.6,  129.4,  129.6,  131.1,  134.0,  139.7, 144.2,  161.5,  162.1, 
167.0, 168.4(C=O). ESI-MS 342 [M+H]
+. Anal. calcd. For C17H15N3O3S:  C, 59.81; H, 4.43; N, 12.31, 
S, 9.39; Found: C, 59.77; H, 4.40; N, 12.28; S, 9.35.  
 
4-Hydroxy-3-{2-[N′-(4-methoxy-benzylidene)-hydrazino]-thiazol-4-yl}-6-methyl-pyran-2-one 
(4j):  
Yield 78%, mp 273-275
oC, Color: light yellow; IR,  υ, cm
–1: 1712 (lactone C=O), 3234 (NH), 3438 
(OH). 
1H NMR (DMSO-d6), δ, ppm: 2.24 (s, 3H, CH3), 3.80 (s, 3H, OCH3), 6.21 (s, 1H, pyran 
proton), 7.13 (d, 2H, J=8.4Hz, ArH), 7.39 (s, 1H, thiazole), 7.64 (d, 2H, J=8.4Hz, ArH), 8.03 (s, 1H, 
CH=N),  11.22  (s,  1H,  -NH),  14.82  (s,  1H,  -OH). 
13C  NMR  (DMSO-d6,  δ  ppm):  19.5(CH3), 
55.3(OCH3),  99.5,  113.7,  114.4,  129.1,  130.4,  131.3,  160.7,  161.7,  162.2,  163.8,  163.9,  164.2, 
170.1(C=O). ESI-MS 358 [M+H]
+. Anal. calcd. For C17H15N3O4S: C, 57.13; H, 4.23; N, 11.76, S, 
8.97;  Found: C, 57.10; H, 4.20;  N, 11.71; S, 8.92.   
 
 
 
General procedure for the preparation of compounds 6: 
An  equimolar  mixture  of  3-(2-bromoacetyl)-4-hydroxy-6-methyl-2H-pyran-2-one  (1mmol, 
1eq) and thiosemicarbazide (1mmol, 1eq) with acetyl acetone (1 mL) on stirring at room temperature 
for about 10 min gave the solid. It was filtered and washed with cold methanol. The crude product 
recrystalized from ethanol. 
 
4-Hydroxy-6-methyl-3-(2-(3,5-dimethyl-1H-pyrazol-1-yl)-2H-pyran-2-one (6):  
Yield 88%, mp 217-219
oC, Color: light yellow; IR, υ, cm
–1: 1727 (lactone C=O), 3437 (OH). 
1H NMR 
(DMSO-d6), δ, ppm: 2.22 (s, 3H, CH3), 2.27 (s, 3H, CH3), 2.62 (s, 3H, CH3), 6.20 (s, 2H, pyran proton 
and pyrazole proton), 7.95 (s, 1H, thiazole), 13.27 (s, 1H, -OH). EI-MS 303 [M]
+. Anal. calcd. For 
C14H13N3O3S: C, 55.43; H, 4.32; N, 13.85, S, 10.57; Found: C, 55.40; H, 4.28; N, 13.81; S, 10.52. 
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